GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » ROC (Joel Greenblatt) %

OrbusNeich Medical Group Holdings (FRA:Q8T) ROC (Joel Greenblatt) % : 57.57% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is OrbusNeich Medical Group Holdings ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. OrbusNeich Medical Group Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 57.57%.

The historical rank and industry rank for OrbusNeich Medical Group Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:

FRA:Q8T' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 7.66   Med: 41.48   Max: 78.4
Current: 51.65

During the past 6 years, OrbusNeich Medical Group Holdings's highest ROC (Joel Greenblatt) % was 78.40%. The lowest was 7.66%. And the median was 41.48%.

FRA:Q8T's ROC (Joel Greenblatt) % is ranked better than
88.88% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 1.605 vs FRA:Q8T: 51.65

OrbusNeich Medical Group Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


OrbusNeich Medical Group Holdings ROC (Joel Greenblatt) % Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings ROC (Joel Greenblatt) % Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial 23.99 7.91 42.87 77.30 51.14

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.16 92.84 63.42 57.57 48.90

Competitive Comparison of OrbusNeich Medical Group Holdings's ROC (Joel Greenblatt) %

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrbusNeich Medical Group Holdings's ROC (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's ROC (Joel Greenblatt) % falls into.


;
;

OrbusNeich Medical Group Holdings ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(34.815 + 37.988 + 4.401) - (11.859 + 0 + 15.21)
=50.135

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(33.131 + 45.441 + 0.55200000000002) - (10.855 + 0 + 17.114)
=51.155

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of OrbusNeich Medical Group Holdings for the quarter that ended in Jun. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=39.782/( ( (15.703 + max(50.135, 0)) + (21.221 + max(51.155, 0)) )/ 2 )
=39.782/( ( 65.838 + 72.376 )/ 2 )
=39.782/69.107
=57.57 %

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrbusNeich Medical Group Holdings  (FRA:Q8T) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


OrbusNeich Medical Group Holdings ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


OrbusNeich Medical Group Holdings Business Description

Traded in Other Exchanges
Address
3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's majority revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

OrbusNeich Medical Group Holdings Headlines

No Headlines